3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one

C39H37N3O2 — CID 70043432

IUPAC3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one
SMILESCCCc1c2c(n3ccccc13)C(=O)C(C(O)c1ncn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c1C)CC2
InChIInChI=1S/C39H37N3O2/c1-3-15-31-32-23-24-33(38(44)36(32)41-25-14-13-22-34(31)41)37(43)35-27(2)42(26-40-35)39(28-16-7-4-8-17-28,29-18-9-5-10-19-29)30-20-11-6-12-21-30/h4-14,16-22,25-26,33,37,43H,3,15,23-24H2,1-2H3
InChIKeyMERKBVUIIPQOHM-UHFFFAOYSA-N
MW579.74 g/mol
LogP7.72
Rot. Bonds8

About 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one

3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one (PubChem CID 70043432) has the molecular formula C39H37N3O2 and a molecular weight of 579.74 g/mol. Its IUPAC name is 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one.

Molecular Properties

Compound Name3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one
PubChem CID70043432
Molecular FormulaC39H37N3O2
Molecular Weight579.74 g/mol
Exact Mass579.29
IUPAC Name3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one
SMILESCCCc1c2c(n3ccccc13)C(=O)C(C(O)c1ncn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c1C)CC2
InChIInChI=1S/C39H37N3O2/c1-3-15-31-32-23-24-33(38(44)36(32)41-25-14-13-22-34(31)41)37(43)35-27(2)42(26-40-35)39(28-16-7-4-8-17-28,29-18-9-5-10-19-29)30-20-11-6-12-21-30/h4-14,16-22,25-26,33,37,43H,3,15,23-24H2,1-2H3
InChIKeyMERKBVUIIPQOHM-UHFFFAOYSA-N
XLogP7.72
TPSA59.53 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500579.74
LogP ≤ 57.72
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one?
The IUPAC name of 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one (CID 70043432) is 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one.
What is the SMILES notation for 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one?
The canonical SMILES for 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one is CCCc1c2c(n3ccccc13)C(=O)C(C(O)c1ncn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c1C)CC2.
What is the InChIKey of 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one?
The InChIKey is MERKBVUIIPQOHM-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H37N3O2/c1-3-15-31-32-23-24-33(38(44)36(32)41-25-14-13-22-34(31)41)37(43)35-27(2)42(26-40-35)39(28-16-7-4-8-17-28,29-18-9-5-10-19-29)30-20-11-6-12-21-30/h4-14,16-22,25-26,33,37,43H,3,15,23-24H2,1-2H3.
What are the key properties of 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one?
3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one has a molecular weight of 579.74 g/mol, XLogP of 7.72, 8 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[hydroxy-(5-methyl-1-tritylimidazol-4-yl)methyl]-10-propyl-2,3-dihydro-1H-pyrido[1,2-a]indol-4-one is sourced from PubChem (CID 70043432), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).